Trial intelligence / Profile preview

Multimodal Pre-emptive Analgesia in Uterine Artery Embolization

NCT01555073Phase 4Terminated

Sponsor
Northwestern University
Start
Oct 2011
Primary completion
Aug 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of pregabalin and celecoxib in postoperative pain (4 arms), sponsored by Northwestern University. Primary endpoint: Post Operative Pain Control at 12 weeks. Started Oct 2011; status: terminated.

02

Drugs

pregabalincelecoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01555073.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01555073.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call